Country · Healthcare markets
France healthcare markets
178 reports across 5 categories, with market size and growth to 2033.
France healthcare markets178 reports across 5 categories, with market size and growth to 2033.
2023–2033 CAGR · estimates
Market size in 2023 · share of the world market
Active trials (recruiting, about to start or running)
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Bayer AG15 reports
Merck & Co., Inc.15 reports
Sanofi15 reports
IBM Watson Health13 reports
Each market name opens its France report. To compare one market across every country, see market statistics.
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| 3D Laparoscopy Imaging Systems | $88 Mn | $153 Mn | 5.7% | 2.8% | 2 |
| 3D Printed Implants | $99 Mn | $322 Mn | 12.5% | 2.8% | 4 |
| 3D Printing in Medical Application | $66 Mn | $385 Mn | 19.3% | 2.8% | 12 |
| Artificial Intelligence (AI) in Drugs Discovery | $17 Mn | $155 Mn | 25.1% | 2.8% | 38 |
| Artificial Intelligence (AI) in Healthcare | – | – | – | – | 169 |
| Artificial Intelligence (AI) in Life Sciences | $61 Mn | $596 Mn | 25.7% | 2.8% | 114 |
| Artificial Intelligence (AI) in Medical Imaging | $25 Mn | $216 Mn | 24.2% | 2.8% | 40 |
| Artificial Intelligence (AI) in Medicine | $228 Mn | $5.1 Bn | 36.5% | – | 169 |
| Artificial Intelligence (AI) in Pharma | – | – | – | – | 38 |
| Artificial Intelligence (AI) in Radiology | $17 Mn | $189 Mn | 27.6% | 2.8% | 7 |
| Artificial Intelligence (AI) in Remote Patient Monitoring | $25 Mn | $326 Mn | 29.4% | 2.8% | 3 |
| Artificial Intelligence (AI) Machine Learning(ML) in Healthcare | $52 Mn | $1.2 Bn | 37% | 2.7% | 169 |
| Blockchain in Genomics | $61 Mn | $1.5 Bn | 37.3% | 2.7% | 0 |
| Blockchain-as-a-Service | $58 Mn | $696 Mn | 28.3% | 2.8% | 0 |
| Brain Imaging, Biomarkers and NeuroInformatics | $19 Mn | $27 Mn | 3.7% | 2.8% | 404 |
| Brain PET-MRI Systems | $9 Mn | $16 Mn | 5.5% | 2.8% | 116 |
| Clinical Alarm Management | $48 Mn | $60 Mn | 2.3% | 2.7% | 13 |
| Clinical Data Management Systems | $69 Mn | $194 Mn | 10.9% | 2.8% | 9 |
| Connected Healthcare Market | $1.6 Bn | $16.4 Bn | 26.1% | 2.8% | 38 |
| Decentralized Clinical Trials(DCTs) | $45 Mn | $164 Mn | 13.8% | 2.8% | 178 |
| Dental 3D Printing | $93 Mn | $554 Mn | 19.5% | 2.7% | 1 |
| Dental CAD/CAM | $91 Mn | $216 Mn | 9% | 2.8% | 3 |
| Digital Biomarkers | $121 Mn | $2.3 Bn | 34.5% | 2.8% | 80 |
| Digital diabetes care | $353 Mn | $1.9 Bn | 18.3% | 2.7% | 24 |
| Digital Pathology Systems | $33 Mn | $109 Mn | 12.7% | 2.8% | 141 |
| Digital Therapeutics | $187 Mn | $1.2 Bn | 20% | 2.8% | 287 |
| Digital Twin | $47 Mn | $380 Mn | 23.3% | 2.7% | 5 |
| Digital X-ray | $479 Mn | $765 Mn | 4.8% | 2.8% | 287 |
| Electronic Health Record | $993 Mn | $1.4 Bn | 3.2% | 2.8% | 49 |
| Healthcare Information System | $8 Bn | $35.5 Bn | 16.1% | 2.8% | 411 |
| Healthcare IT | $13.3 Bn | $39.1 Bn | 11.4% | 2.8% | 70 |
| Home Healthcare | $10 Bn | $19.4 Bn | 6.9% | 2.8% | 444 |
| Internet Of Things In Healthcare | $2.7 Bn | $12.1 Bn | 16% | 2.8% | 1 |
| IoT in Healthcare | $5 Bn | $22.1 Bn | 16.1% | 2.8% | 1 |
| Long-term Care Software | $96 Mn | $288 Mn | 11.6% | 2.8% | 41 |
| Mental Health Apps | $154 Mn | $930 Mn | 19.7% | 2.8% | 16 |
| Pathology Imaging Systems | $45 Mn | $125 Mn | 10.9% | 2.8% | 141 |
| Point of Care Diagnostics | $1.2 Bn | $2.3 Bn | 6.4% | 2.8% | 867 |
| Remote Medication Management | $107 Mn | $471 Mn | 16% | 2.8% | 33 |
| Remote Patient Monitoring | $44 Mn | $205 Mn | 16.8% | 2.8% | 88 |
| Werable Healthcare Devices | $897 Mn | $5 Bn | 18.8% | 2.7% | 51 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Alopecia areata | – | – | – | – | 8 |
| Alzheimers Dignostic | $58 Mn | $102 Mn | 5.9% | 2.8% | 98 |
| Ambulance Service | $861 Mn | $1.6 Bn | 6.1% | 2.8% | 136 |
| Ambulatory Surgery Center | $1.1 Bn | $1.8 Bn | 5.1% | 2.8% | 1,271 |
| Antimicrobial Susceptibility Testing | – | – | – | – | 32 |
| Bioinformatics | $336 Mn | $1.2 Bn | 13.4% | 2.8% | – |
| Biomaterial Wound Dressing | $226 Mn | $393 Mn | 5.7% | 2.8% | 11 |
| Blood Gas and Electrolyte Analyzers | $77 Mn | $130 Mn | 5.4% | 2.8% | 84 |
| Bone Cancer Diagnostic | $30 Mn | $56 Mn | 6.4% | 2.8% | 136 |
| Brain Cancer Diagnostic | $41 Mn | $135 Mn | 12.6% | 2.8% | 146 |
| Breast Cancer Diagnostic | $113 Mn | $218 Mn | 6.8% | 2.7% | 383 |
| Clinical Laboratory Service | – | – | – | – | – |
| Dental Care Service | – | – | – | – | – |
| Dental Imaging | $94 Mn | $182 Mn | 6.9% | 2.8% | – |
| Dermatology Diagnostic | $715 Mn | $1.9 Bn | 10.2% | 2.8% | 451 |
| Fertility Service | $578 Mn | $950 Mn | 5.1% | 2.8% | – |
| Healthcare Electronic Data Interchange (EDI) | $110 Mn | $246 Mn | 8.4% | 2.8% | 11 |
| Healthcare In Vitro Diagnostic | $2.3 Bn | $3 Bn | 2.8% | 2.8% | 70 |
| Hospitals and Health Systems | $119.8 Bn | $187.8 Bn | 4.6% | 2.8% | 5,953 |
| Medical Billing | $124 Mn | $333 Mn | 10.4% | 2.7% | 1 |
| Medical Tourism | $2 Bn | $5.9 Bn | 11.2% | 2.8% | 0 |
| Nursing Education | $283 Mn | $562 Mn | 7.1% | 2.8% | 21 |
| Patient Support Programs (PSP) | $473 Mn | $1.9 Bn | 14.8% | 2.8% | 186 |
| Point Of Care (PoC) Molecular Diagnostic | $514 Mn | $1.1 Bn | 8.3% | 2.7% | 60 |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Acute Care Needleless Connectors | $14 Mn | $25 Mn | 6.5% | 2.8% | – |
| Advanced Bipolar Direct Energy Devices | $85 Mn | $179 Mn | 7.7% | 2.8% | – |
| Aesthetic Lasers and Energy Devices | $45 Mn | $128 Mn | 11.1% | 2.8% | – |
| Air Ambulance Life Support Solutions | $123 Mn | $268 Mn | 8.1% | 2.7% | – |
| Airway Management Devices | $55 Mn | $83 Mn | 4.2% | 2.8% | – |
| Anastomosis Devices | $87 Mn | $152 Mn | 5.8% | 2.7% | – |
| Anesthesia & Respiratory Devices | $789 Mn | $1.8 Bn | 8.5% | 2.8% | – |
| Anesthesia Monitoring Devices | $73 Mn | $216 Mn | 11.5% | 2.8% | – |
| Angiography Devices | $342 Mn | $574 Mn | 5.3% | 2.8% | – |
| Angioplasty Balloons | $112 Mn | $147 Mn | 2.8% | 2.7% | – |
| Anti-Snoring Devices | $34 Mn | $73 Mn | 7.8% | 2.8% | – |
| Apheresis Equipments | $70 Mn | $116 Mn | 5.2% | 2.7% | – |
| Arrhythmia Monitoring Devices | $165 Mn | $257 Mn | 4.5% | 2.8% | – |
| Assisted Walking Aids | $63 Mn | $98 Mn | 4.5% | 2.8% | – |
| Audiology Devices | $215 Mn | $364 Mn | 5.4% | 2.7% | – |
| Defibrillator | $488 Mn | $787 Mn | 4.9% | 2.8% | – |
| Dental Articulators | $11 Mn | $18 Mn | 5.4% | 2.7% | – |
| Dental Caries Detectors | $10 Mn | $28 Mn | 10.8% | 2.8% | – |
| Dental Diagnostic and Surgical Equipments | $330 Mn | $596 Mn | 6.1% | 2.8% | – |
| Dental X-Ray Equipments | $48 Mn | $88 Mn | 6.2% | 2.7% | – |
| Diabetes Care Devices | $1.2 Bn | $1.9 Bn | 4.9% | 2.8% | – |
| Digital Diabetes Management | – | – | – | – | – |
| Direct Energy Medical Devices | $304 Mn | $449 Mn | 4% | 2.8% | – |
| Disposable Surgical Devices | $249 Mn | $458 Mn | 6.3% | 2.8% | – |
| Insulin Delivery Devices | $437 Mn | $746 Mn | 5.5% | 2.8% | – |
| Insulin Patch Pumps | $25 Mn | $70 Mn | 11% | 2.8% | – |
| Rehabilitation Equipments | $550 Mn | $905 Mn | 5.1% | 2.8% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Adaptogens | $223 Mn | $459 Mn | 7.5% | 2.8% | – |
| Amino Acid | – | – | – | – | – |
| Anthelmintic Drug | – | – | – | – | – |
| Antioxidants | – | – | – | – | – |
| Antipyretics OTC | – | – | – | – | – |
| BCAA Supplement | $39 Mn | $67 Mn | 5.7% | 2.8% | – |
| Beauty Supplements | $113 Mn | $248 Mn | 8.2% | 2.7% | – |
| Biotin Supplement | $11 Mn | $16 Mn | 4% | 2.8% | – |
| Bone & Joint Health Supplements | $330 Mn | $558 Mn | 5.4% | 2.8% | – |
| Calcium Supplements | $69 Mn | $112 Mn | 5% | 2.8% | – |
| Cannabidiol (CBD) Supplements | $146 Mn | $632 Mn | 15.8% | 2.7% | – |
| Cardiovascular Health Supplements | $187 Mn | $296 Mn | 4.7% | 2.8% | – |
| Clinical Nutrition | $784 Mn | $1.4 Bn | 6.1% | 2.8% | – |
| Coenzyme Q10 | $14 Mn | $30 Mn | 8% | 2.8% | – |
| Collagen Supplements | $61 Mn | $100 Mn | 5.1% | 2.8% | – |
| Creatine | $17 Mn | $28 Mn | 5.3% | 2.8% | – |
| Dietary Supplements | $8.5 Bn | $14.1 Bn | 5.2% | 2.8% | – |
| Eye Health Supplements | $85 Mn | $142 Mn | 5.2% | 2.8% | – |
| Functional Food | $7.8 Bn | $13.6 Bn | 5.7% | 2.8% | – |
| Hair Growth Supplements | $50 Mn | $91 Mn | 6.3% | 2.8% | – |
| Herbal Supplements | $2.3 Bn | $4.3 Bn | 6.6% | 2.8% | – |
| Immune Health Supplement | – | – | – | – | – |
| Iron Supplement | $55 Mn | $94 Mn | 5.5% | 2.8% | – |
| Men's Health Supplements | $498 Mn | $875 Mn | 5.8% | 2.8% | – |
| Mood and Stress Supplements | $289 Mn | $573 Mn | 7.1% | 2.8% | – |
| Nutritional Supplements | $10.6 Bn | $18.6 Bn | 5.8% | 2.8% | – |
| Omega 3 Fatty Acid | $113 Mn | $210 Mn | 6.4% | 2.7% | – |
| Oncology Nutrition | $58 Mn | $106 Mn | 6.3% | 2.8% | – |
| Osteoporosis Supplements | $85 Mn | $146 Mn | 5.5% | 2.8% | – |
| Over The Counter (OTC) Analgesics | $605 Mn | $767 Mn | 2.4% | 2.8% | – |
| Over The Counter (OTC) Antifungal | $69 Mn | $91 Mn | 2.8% | 2.8% | – |
| Over The Counter (OTC) Consumer | $4.2 Bn | $6.3 Bn | 4.2% | 2.8% | – |
| Over The Counter (OTC) Drugs | $4.9 Bn | $7 Bn | 3.7% | 2.8% | – |
| Over The Counter (OTC) Gastrointestinal Drugs | $154 Mn | $205 Mn | 2.9% | 2.8% | – |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | $399 Mn | $541 Mn | 3.1% | 2.7% | – |
| Over The Counter (OTC) Ophthalmic Drugs | $99 Mn | $140 Mn | 3.5% | 2.8% | – |
| Over The Counter (OTC) Pharmaceuticals | $4.9 Bn | $7 Bn | 3.7% | 2.8% | – |
| Over The Counter (OTC) Sleep Aid Products | $146 Mn | $196 Mn | 3% | 2.7% | – |
| Over The Counter (OTC) Vitamins and Minerals | $880 Mn | $1.4 Bn | 4.5% | 2.8% | – |
| Plant-Based Supplements | $338 Mn | $665 Mn | 7% | 2.7% | – |
| Prebiotics | $223 Mn | $621 Mn | 10.8% | 2.8% | – |
| Probiotic Supplements for Gut Health | $168 Mn | $306 Mn | 6.2% | 2.7% | – |
| Protein Supplement | $550 Mn | $1 Bn | 6.4% | 2.8% | – |
| Sports Nutrition | $1.4 Bn | $2.8 Bn | 6.9% | 2.8% | – |
| Vitamin B12(Cobalamin) | $8 Mn | $13 Mn | 4.5% | 2.8% | – |
| Vitamin D Supplements | – | – | – | – | – |
| Weight Management Supplement | – | – | – | – | – |
| Women's Health Supplements | $550 Mn | $967 Mn | 5.8% | 2.8% | – |
| Market | 2023 | 2033 (projected) | CAGR | World share | Active trials |
|---|---|---|---|---|---|
| Abuse Deterrent Opioids | – | – | – | – | – |
| Alexipharmic Drugs | – | – | – | – | – |
| Alopecia Drugs (Hair Loss) | – | – | – | – | – |
| Alzheimer Drugs | $138 Mn | $242 Mn | 5.8% | – | – |
| Aminoglycosides | – | – | – | – | – |
| Anemia Drugs | – | – | – | – | – |
| Anti-Aging | $2.4 Bn | $4.8 Bn | 7.1% | 2.8% | – |
| Anti-Depressants Drugs | $495 Mn | $586 Mn | 1.7% | 2.8% | – |
| Anti-Nerve Growth Factor | – | – | – | – | – |
| Anti-Venom | – | – | – | – | – |
| Anticoagulants | – | – | – | – | – |
| Antithrombotic Drugs | – | – | – | – | – |
| Artificial Skin | $69 Mn | $110 Mn | 4.8% | 2.8% | – |
| Asthma & COPD Drugs | $1.4 Bn | $1.8 Bn | 3% | 2.8% | – |
| Atherosclerosis Drugs | – | – | – | – | – |
| Atopic Dermatitis Drugs | $309 Mn | $893 Mn | 11.2% | 2.7% | – |
| Autologous Matrix-induced Chondrogenesis | – | – | – | – | – |
| Axial Spondyloarthritis (axSpA) | – | – | – | – | – |
| Biological Safety Testing | – | – | – | – | – |
| Biosimilar Monoclonal Antibodies | – | – | – | – | – |
| Biosimilars | $1 Bn | $8.7 Bn | 23.9% | 2.8% | – |
| Blood Plasma | – | – | – | – | – |
| Bone Marrow Aspirate Concentrates | – | – | – | – | – |
| Burn Care | – | – | – | – | – |
| Burn Ointment | – | – | – | – | – |
| Cancer Supportive Care Drugs | $682 Mn | $981 Mn | 3.7% | 2.8% | – |
| Cannabidiol (CBD) | $606 Mn | $2.6 Bn | 15.8% | 2.8% | – |
| Cannabis | $932 Mn | $3 Bn | 12.5% | 2.7% | – |
| Cell Based Immunotherapy | $457 Mn | $3.3 Bn | 22% | 2.8% | – |
| Contraceptives Drugs | $693 Mn | $1.2 Bn | 5.8% | 2.8% | – |
| Cord Blood Banking Service | $52 Mn | $89 Mn | 5.5% | 2.7% | – |
| Diabetes Management | $2.1 Bn | $3.9 Bn | 6.1% | 2.8% | – |
| Diabetic Retinopathy Drugs | $297 Mn | $484 Mn | 5% | 2.8% | – |
| Epilepsy Drugs | $264 Mn | $338 Mn | 2.5% | 2.8% | – |
| Gastroesophageal Reflux Disease (GERD) Drugs | $143 Mn | $160 Mn | 1.1% | 2.8% | – |
| Gastrointestinal Drugs | $1.5 Bn | $2.1 Bn | 3.6% | 2.8% | – |
| HIV Drugs | $825 Mn | $1.3 Bn | 4.8% | 2.8% | – |
| Oncology/Cancer Drugs | $4.9 Bn | $9.9 Bn | 7.4% | 2.8% | – |
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.